Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: IMARC Services Private Limited | PRODUCT CODE: 1127809

Cover Image

PUBLISHER: IMARC Services Private Limited | PRODUCT CODE: 1127809

United States Specialty Generics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

PUBLISHED:
PAGES: 112 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 2699
PDF (5 User License)
USD 3699
PDF (Corporate License)
USD 4699

Add to Cart

The United States specialty generics market size reached US$ 23.6 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 43.1 Billion by 2027, exhibiting a growth rate (CAGR) of 10.37% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Specialty generic drugs are the generic versions of specialty branded drugs once they lose patent protection. These drugs are used to treat life threatening and serious health conditions such as cancer, autoimmune diseases, epilepsy, HIV, hepatitis, multiple sclerosis, rheumatoid arthritis, etc.

Specialty generics are economical compared to specialty drugs as they don't need to undergo the costly and time-consuming research and development procedures required for their branded versions. Moreover, marketing and promotional expenses for speciality generics are also lower compared to their branded versions. This results in significant savings for patients, government and healthcare providers. Moreover, the market is also being catalysed by a rising ageing population in the United States. This has resulted in an increasing prevalence of various life-threatening diseases such as cancer, multiple sclerosis, hepatitis, HIV, autoimmune disease, etc. For instance, the American cancer society estimated a total of 1,762,450 new cancer cases and 606,880 deaths from cancer in the United States for 2019. Additionally, the patent expiration of several blockbuster branded specialty drugs is further expected to catalyse the market growth in the coming years.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the United States specialty generics market report, along with forecasts for the period 2022-2027. Our report has categorized the market based on route of administration, therapeutic application and distribution channel.

Breakup by Route of Administration:

  • Injectables
  • Oral
  • Others

Breakup by Therapeutic Application:

  • Oncology
  • Hepatitis
  • Multiple Sclerosis
  • HIV
  • Other Autoimmune Diseases
  • Others

Breakup by Distribution channel:

  • Retail Pharmacies
  • Specialty Pharmacies
  • Hospital Pharmacies

Competitive Landscape:

  • The leading players in the US specialty generics industry have also been examined in the report.
  • Key Questions Answered in This Report
  • 1. What was the size of the United States specialty generics market in 2021?
  • 2. What is the expected growth rate of the United States specialty generics market during 2022-2027?
  • 3. What are the key factors driving the United States specialty generics market?
  • 4. What has been the impact of COVID-19 on the United States specialty generics market?
  • 5. What is the breakup of the United States specialty generics market based on the route of administration?
  • 6. What is the breakup of the United States specialty generics market based on the therapeutic application?
  • 7. What is the breakup of the United States specialty generics market based on the distribution channel?
Product Code: SR1022A78_Report

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Global Specialty Generics Market: Introduction

  • 4.1 What are Specialty Generic Drugs?
  • 4.2 Types of Specialty Generics

5 Why are Specialty Generics So Lucrative?

6 Global Specialty Generics Market

  • 6.1 Market Overview
  • 6.2 Market Performance
  • 6.3 Market Breakup by Route of Administration
  • 6.4 Market Breakup by Therapeutic Application
  • 6.5 Market Breakup by Distribution Channel
  • 6.6 Market Breakup by Region
  • 6.7 Market Forecast

7 US Specialty Generics Market

  • 7.1 Market Overview
  • 7.2 Market Performance
  • 7.3 Impact of COVID-19
  • 7.4 Market Breakup by Route of Administration
  • 7.5 Market Breakup by Therapeutic Application
  • 7.6 Market Breakup by Distribution Channel
  • 7.7 Market Forecast
  • 7.8 SWOT Analysis
    • 7.8.1 Overview
    • 7.8.2 Strengths
    • 7.8.3 Weaknesses
    • 7.8.4 Opportunities
    • 7.8.5 Threats
  • 7.9 Value Chain Analysis
  • 7.10 Porters Five Forces Analysis
    • 7.10.1 Overview
    • 7.10.2 Bargaining Power of Buyers
    • 7.10.3 Bargaining Power of Suppliers
    • 7.10.4 Degree of Competition
    • 7.10.5 Threat of New Entrants
    • 7.10.6 Threat of Substitutes
  • 7.11 Key Market Drivers and Success Factors

8 Market Breakup by Route of Administration

  • 8.1 Injectables
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Oral
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.1 Market Forecast

9 Market Breakup by Therapeutic Application

  • 9.1 Oncology
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Hepatitis
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Multiple Sclerosis
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 HIV
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Other Autoimmune Diseases
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast
  • 9.6 Others
    • 9.6.1 Market Trends
    • 9.6.2 Market Forecast

10 Market Breakup by Distribution Channel

  • 10.1 Retail Pharmacies
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Specialty Pharmacies
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Hospital Pharmacies
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Competitive Landscape

  • 11.1 Market Structure
  • 11.2 Key Players
  • 11.3 Profiles of Key Players
Product Code: SR1022A78_Report

List of Figures

  • Figure 1: US: Specialty Generics Market: Major Drivers and Challenges
  • Figure 2: Global: Specialty Generics Market: Sales Value (in Billion US$), 2016-2021
  • Figure 3: Global: Specialty Generics Market: Breakup by Route of Administration (in %), 2021
  • Figure 4: Global: Specialty Generics Market: Breakup by Therapeutic Application (in %), 2021
  • Figure 5: Global: Specialty Generics Market: Breakup by Distribution Channel (in %), 2021
  • Figure 6: Global: Specialty Generics Market: Breakup by Region (in %), 2021
  • Figure 7: Global: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2022-2027
  • Figure 8: US: Specialty Generics Market: Sales Value (in Billion US$), 2016-2021
  • Figure 9: US: Specialty Generics Market: Breakup by Route of Administration (in %), 2021
  • Figure 10: US: Specialty Generics Market: Breakup by Therapeutic Application (in %), 2021
  • Figure 11: US: Specialty Generics Market: Breakup by Distribution Channel (in %), 2021
  • Figure 12: US: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2022-2027
  • Figure 13: US: Specialty Generics Industry: SWOT Analysis
  • Figure 14: US: Specialty Generics Industry: Value Chain Analysis
  • Figure 15: US: Specialty Generics Industry: Porter's Five Forces Analysis
  • Figure 16: US: Specialty Generics Market (Administration through Injectables): Sales Value (in Million US$), 2016 & 2021
  • Figure 17: US: Specialty Generics Market (Administration through Injectables) Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 18: US: Specialty Generics Market (Oral Administration): Sales Value (in Million US$), 2016 & 2021
  • Figure 19: US: Specialty Generics Market (Oral Administration) Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 20: US: Specialty Generics Market (Other Routes of Administration): Sales Value (in Million US$), 2016 & 2021
  • Figure 21: US: Specialty Generics Market (Other Routes of Administration) Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 22: US: Specialty Generics Market (Oncology): Sales Value (in Million US$), 2016 & 2021
  • Figure 23: US: Specialty Generics Market (Oncology) Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 24: US: Specialty Generics Market (Hepatitis): Sales Value (in Million US$), 2016 & 2021
  • Figure 25: US: Specialty Generics Market (Hepatitis) Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 26: US: Specialty Generics Market (Multiple Sclerosis): Sales Value (in Million US$), 2016 & 2021
  • Figure 27: US: Specialty Generics Market (Multiple Sclerosis) Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 28: US: Specialty Generics Market (HIV): Sales Value (in Million US$), 2016 & 2021
  • Figure 29: US: Specialty Generics Market (HIV) Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 30: US: Specialty Generics Market (Other Autoimmune Diseases): Sales Value (in Million US$), 2016 & 2021
  • Figure 31: US: Specialty Generics Market (Other Autoimmune Diseases) Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 32: US: Specialty Generics Market (Other Applications): Sales Value (in Million US$), 2016 & 2021
  • Figure 33: US: Specialty Generics Market (Other Applications) Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 34: US: Specialty Generics Market: Sales Through Retail Pharmacies (in Million US$), 2016 & 2021
  • Figure 35: US: Specialty Generics Market Forecast: Sales Through Retail Pharmacies (in Million US$), 2022-2027
  • Figure 36: US: Specialty Generics Market: Sales Through Specialty Pharmacies (in Million US$), 2016 & 2021
  • Figure 37: US: Specialty Generics Market Forecast: Sales Through Specialty Pharmacies (in Million US$), 2022-2027
  • Figure 38: US: Specialty Generics Market: Sales Through Hospital Pharmacies (in Million US$), 2016 & 2021
  • Figure 39: US: Specialty Generics Market Forecast: Sales Through Hospital Pharmacies (in Million US$), 2022-2027

List of Tables

  • Table 1: Global: Specialty Generics Market: Key Industry Highlights, 2021 and 2027
  • Table 2: US: Specialty Generics Market: Key Industry Highlights, 2021 and 2027
  • Table 3: US: Specialty Generics Market Forecast: Breakup by Route of Administration (in Million US$), 2022-2027
  • Table 4: US: Specialty Generics Market Forecast: Breakup by Therapeutic Application (in Million US$), 2022-2027
  • Table 5: US: Specialty Generics Market Forecast: Breakup by Distribution Channel (in Million US$), 2022-2027
  • Table 6: US: Specialty Generics Market: Competitive Structure
  • Table 7: US: Specialty Generics Market: Key Players
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!